Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Validity of the National Health Security Preparedness Index as a Predictor of Excess COVID-19 Mortality

researchsnappy by researchsnappy
January 6, 2021
in Healthcare Research
0
Hip Arthroscopy for Femoroacetabular Impingement: 1-Year Outcomes Predict 5-Year Outcomes
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

This article was originally published here

Prehosp Disaster Med. 2021 Jan 5:1-13. doi: 10.1017/S1049023X20001521. Online ahead of print.

ABSTRACT

OBJECTIVE: This study compared 2019 values for the National Health Security Preparedness Index (NHSPI) with rates of coronavirus disease 2019 (COVID-19)-related mortality as reported by the 50 US states and Puerto Rico during the first six months of the US pandemic (March 1 – August 31, 2020).

METHODS: Data regarding provisional death counts and estimates of excess deaths for COVID-19 according to state and territory were downloaded from the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics website. Reporting included the six-month-long period of March 1 – August 31, 2020. Excess mortality rates were calculated as the number of excess deaths per 100,000 persons in each state population using 2019 US Census Bureau data. Mean values for state and territorial NHSPI domain indices were compared to state and territorial rates of COVID-19-related excess mortality using multiple linear regression, including analysis of variance. Correlations between the 51 state and territorial NHSPI values and corresponding COVID-19 excess mortality rates were calculated using Pearson’s correlation coefficient.

RESULTS: These calculations revealed a high degree of variance (adjusted r square = 0.02 and 0.25) and poor correlation (P = .16 and .08) among values for the overall NHSPI as compared to low and high estimates of excess COVID-19 mortality rates for 50 US states and Puerto Rico.There was also a high degree of variance (adjusted r square = 0.001 and 0.03) and poor correlation (P values ranging from .09 to .94) for values for the six individual domains of the NHSPI as compared to low and high estimates of excess COVID-19 mortality rates for 50 US states and Puerto Rico.

CONCLUSION: The NHSPI does not appear to be a valid predictor of excess COVID-19 mortality rates for 50 US states and Puerto Rico during the first six months of the pandemic.

PMID:33397547 | DOI:10.1017/S1049023X20001521

Previous Post

Citi poaches Lucy Baldwin from Credit Suisse to lead equity research

Next Post

Pharmaceutical Water Market Research With Size, Growth, Key Players, Segments And Forecasts Analysis 2020-2026| Merck KGaA, B. Braun Melsungen, Baxter International, Thermo Fisher Scientific

Next Post
Pharmaceutical Water Market Research With Size, Growth, Key Players, Segments And Forecasts Analysis 2020-2026| Merck KGaA, B. Braun Melsungen, Baxter International, Thermo Fisher Scientific

Pharmaceutical Water Market Research With Size, Growth, Key Players, Segments And Forecasts Analysis 2020-2026| Merck KGaA, B. Braun Melsungen, Baxter International, Thermo Fisher Scientific

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com